Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 9, 2022Blood ReviewsOpen Access

Determinants of severity in sickle cell disease

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDavid C. ReesKing's College HospitalVBValentine BrousseUniversité Paris CitéJBJohn BrewinKing's College Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rees et al. (2022) studied this question.

synapsesocial.com/papers/6a036b04e45623d3679bd3dahttps://doi.org/10.1016/j.blre.2022.100983
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The rationale for using hydroxycarbamide in the treatment of sickle cell disease2011 · 49 citations
  2. 2Influence of Bilirubin Uridine Diphosphate– Glucuronosyltransferase 1A Promoter Polymorphisms on Serum Bilirubin Levels and Cholelithiasis in Children With Sickle Cell Anemia2001 · 108 citations
  3. 3Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans2010 · 2,066 citations
  4. 4Pathophysiology of Sickle Cell Disease2018 · 808 citations
  5. 5G6PD deficiency, absence of α-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia2008 · 163 citations